Modified vs. Conventional Laparoscopic TAPP for Inguinal Hernia (NCT07373314) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Modified vs. Conventional Laparoscopic TAPP for Inguinal Hernia
60 participantsStarted 2026-02-10
Plain-language summary
This study aims to compare the outcomes of two laparoscopic techniques for repairing inguinal hernias: the modified tumescent technique (MT-TAPP) and the conventional laparoscopic transabdominal preperitoneal technique (CL-TAPP). The primary goal is to determine which technique provides better outcomes in terms of operative time, ease of pre-peritoneal space dissection, postoperative pain, and the formation of seromas. The study will involve 60 patients diagnosed with unilateral inguinal hernias, randomly assigned to either group. Participants in Group A will undergo the MT-TAPP procedure, which involves pre-peritoneal infiltration of a local anesthetic solution to improve dissection and reduce pain. Group B will undergo the standard CL-TAPP procedure. Data will be collected on various outcome measures and analyzed to identify which technique leads to quicker recovery, less postoperative pain, and fewer complications. The results of this study will help guide surgical decisions and improve patient outcomes in inguinal hernia repair.
Who can participate
Age range
18 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age: 18 to 50 years.
* Gender: Both male and female participants.
* Condition: Diagnosed with unilateral inguinal hernia (as per operational definition).
* Health Status: ASA I-III (American Society of Anesthesiologists physical status classification), indicating that the patient is fit for surgery.
* Consent: Participants must be able to provide informed consent to participate in the study.
Exclusion Criteria:
* Femoral Hernias.
* Incarcerated or Strangulated Hernia.
* Recurrent Hernias (as per medical record).
* Serious Systemic Diseases:
* Conditions such as heart failure or coagulation problems (e.g., PT \> 15 sec).
* ASA III-V classification, indicating a higher risk for surgery.
* Pregnancy (if applicable).
* Allergy to Anesthesia or the substances used in the tumescent solution (lidocaine, epinephrine, saline).
* Uncontrolled Diabetes or other medical conditions that might interfere with the healing process.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain Score
Timeframe: Recorded 24 hours post-surgery.
2
Seroma Formation:
Timeframe: Presence or absence of seroma, assessed during the 7-day postoperative follow-up.